Ensuring equitable and sustainable access to medicines through a secure and resilient supply
Date
Address
Section
Event Description
We are glad to invite you to the event “Ensuring equitable and sustainable access to medicines through a secure and resilient supply”, which will take place at the premises of the Permanent Representation of the Czech Republic to the European Union (Rue Caroly 15, 1050 Bruxelles) on Thursday 10 November 2022, from 10:00 to 13:00 (preceded by registration and welcome coffee from 09:15 to 10:00 and followed by a buffet lunch after 13:00).
This in-person initiative is organised by Medicines for Europe and ČAFF - Czech Association of Pharmaceutical Companies, under the patronage of the Czech Presidency of the Council of the European Union.
High-level speakers and panellists from the EU and Czech institutions, including the Czech Deputy Ministers for Health, Jakub Dvořáček, and Industry and Trade, Marian Piecha, will discuss with distinguished speakers from the patient, academic and payer community, as well as the industry, how to:
1. Improve patient access to medicines in Central and Eastern Europe, building also on the recent Medicines for Europe report which highlighted the key role generic and biosimilar medicines can play in this regard.
2. Increase manufacturing resilience to secure the supply of off-patent medicines and Active Pharmaceutical Ingredients to achieve a European Open Strategic Autonomy.
Kindly find below the draft programme.
We would be delighted if you could join the initiative. We would kindly ask you to register by Monday 7 November COB, by following this LINK. Registration is required to access the Czech Republic Permanent Representation.
We look forward to seeing you on 10 November!
***
P R O G R A M M E
Ensuring equitable and sustainable access to medicines through a secure and resilient supply
10 November 2022 - from 10:00 to 13:00
At the premises of the Permanent Representation of the Czech Republic to the European Union, Rue Caroly 15, 1050 Ixelles
09:15-10:00
Registration and welcome coffee
10:00-10:15
Introductory remarks
- Jakub Dvořáček – Deputy Minister, Ministry of Health of the Czech Republic
- Elisabeth Stampa – Medicines for Europe President and CEO Medichem
- Ondřej Knotek – Member of the European Parliament (invited)
- Andrzej Rys - Principal Scientific Adviser, Directorate General Health and Food Safety, European Commission (invited)
10:15-11:20
Session 1: Sustainable and equitable access to medicines in Central and Eastern Europe
Equitable access to medicines and the sustainability of healthcare systems remains a challenge for many European governments. In this context, off-patent medicines play an essential role in promoting pharmaceutical innovation and, through competition contribute massively to the affordability, sustainability, and accessibility of healthcare systems. The greater use of generic and biosimilar medicines in the CEE region could be a catalyst to dramatically improve access to medicines and to improve health outcomes, as found in the recent Medicines for Europe report “Removing access barriers in Central and Eastern Europe: How can we ensure equitable access to medicines for all European patients?”
MODERATOR:
Vera Pataki - Head of International Market Access, EGIS and Chair of the CEE Network, Medicines for Europe
PANELLISTS:
- Jakub Dvořáček - Deputy Minister, Ministry of Health of the Czech Republic
- Andrzej Rys - Principal Scientific Adviser, Directorate General Health and Food Safety, European Commission (invited)
- Zoltán Kaló - Professor of Health Economics at Center for Health Technology Assessment, Semmelweis University (invited)
- Gergely Németh - Project Manager, EURIPID at the National Institute of Health Insurance Fund Management (NEAK)
- European Patients’ Forum Representative - (invited)
11:20-11:40
Coffee Break
Session 2: Increasing Manufacturing Resilience for security of supply and equitable access
Cost-containment and the Industrial consolidation of the sector run counter to the EU’s commitment to increase manufacturing resilience and diversity and reduce reliance on third countries. To reverse industrial consolidation and promote open strategic autonomy in medicines manufacturing, the Czech Presidency can stimulate progress on a policy environment that solidifies security of supply for equitable access to medicines.
MODERATOR:
(tbc)
PANELLISTS:
- Marian Piecha - Deputy Minister, Ministry of Industry and Trade of the Czech Republic
- Elisabeth Stampa - Medicines for Europe President and CEO Medichem
- Giacomo Mattinò - Head of Unit, Food, Retail, Health, DG Internal Market, Industry, Entrepreneurship and SMEs, European Commission
- Soňa Porubská - Head of Corporate Affairs Zentiva Global and ČAFF Board member
- Steffen Denzinger - President European Fine Chemicals Group (EFCG) and Director Business Development Actives & Formulation Merck KGaA
12:45-13:00
Concluding remarks
- Marian Piecha - Deputy Minister, Ministry of Industry and Trade of the Czech Republic
- Alexandr Vondra – Member of the European Parliament (invited)
- Philippe Drechsle - Vice President EU Portfolio, TEVA and Medicines for Europe Executive Committee member
13:00
Buffet lunch
